Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction
about
Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivoMolecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury.Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression.Motility, survival, and proliferation.O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cellsPoly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.A novel human anti-VCAM-1 monoclonal antibody ameliorates airway inflammation and remodelling.Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblastsPhosphorylation of p50 NF-kappaB at a single serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatmentCochinchina momordica seed extract induces apoptosis and cell cycle arrest in human gastric cancer cells via PARP and p53 signal pathways.Does airway smooth muscle express an inflammatory phenotype in asthma?Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell functionPoly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axisMicroparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae.DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replicationPARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice.Differential effect of zoledronic acid on human vascular smooth muscle cellsProgressive changes in inflammatory and matrix adherence of bronchial epithelial cells with persistent respiratory syncytial virus (RSV) infection (progressive changes in RSV infection).Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasionTranscriptional regulation of cytokine function in airway smooth muscle cells.The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines.High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors.Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes.VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.The NF-κB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells.Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β.Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.CBP501 suppresses macrophage induced cancer stem cell like features and metastases.Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.E3 ubiquitin ligase NKLAM positively regulates macrophage inducible nitric oxide synthase expression.Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice.
P2860
Q27331780-53B15369-D728-4F94-96D9-F0E5633524ABQ33728199-69EE9A04-C39F-4328-8603-47E8809CCD1EQ33745936-897DC10A-F59A-4C27-BAA5-862C51902D6CQ33997601-71AE5C95-B725-4705-BA2A-2510EFD18784Q34014467-30EB3B0B-CD65-422C-B666-389369D86F5CQ34023297-8392BC85-FC3C-4144-9DD9-90C1E5AEB3E4Q34154758-466DFD4D-C702-4D03-B538-DF947E2F1EFFQ34251323-C2413D66-5096-4BA6-9761-8F7002C2D1BAQ34412835-D937BE7F-80CF-483C-AC30-72C611C5D43FQ34423766-638A4607-9284-484C-800D-037BE6D1B724Q34903113-7A598565-59EB-4248-9DB2-64C419112C57Q35111638-AA4EBDE0-2EDD-42A0-8C6B-4EC111348AF9Q35148141-C0AD3448-AD74-4EF8-A08B-A8E25F093A1DQ35287136-ACE4D2D2-1DC3-4584-BE2A-C435CAB4473EQ35848889-606093CF-9D68-41ED-B38E-7087B57EF0BCQ35857399-587056B8-A91C-4F61-BCF7-7D935DD1C64FQ35927423-08E63E6D-8F77-4EC8-AA93-31D271683241Q36031350-D634D73E-354F-499D-B6AF-FCD4A3081AF8Q36184688-24556DDB-D23D-48AA-B41C-9DBDF60D6BFFQ36746196-07DE439D-E815-49C0-9AC3-EFAF084B0968Q37225085-3ACC2624-A125-49CA-B92B-08B2546D9B54Q37225511-24733301-57AF-4BE3-B808-2A25AE8BD4FBQ37272073-66FBA937-2474-49FC-9790-35D3744D2129Q37329286-561497C3-A1CE-498C-A46F-D978E800BD0EQ37351584-437F4A2A-68E8-4617-857B-9FDC37B38D0BQ37377750-919628A5-5EC2-4265-AB4B-4BA08D8300B1Q37429317-A8A56F5F-20BF-4376-823D-68824ED55D4FQ37441933-DF9C3A49-6592-4304-B6DA-7BB4323EC138Q37644563-965350D6-40EA-4677-9B40-FB3123814BE9Q38714947-030733F6-64F8-4AE3-B960-2A14CE8B3735Q39323558-165968E3-8A6D-4213-A3A9-7C94BF3438DDQ40019330-ACFA661F-3E33-4D8D-9335-3307BABAE261Q40181345-25BC2007-9117-49A0-9AEF-6541337E1A58Q41505946-3B6A3D23-FAFE-4669-8CC8-F3D311760147Q41820940-ED0E5649-2E7F-42AE-8570-8339F9A268E8Q41873851-D7B5CF0C-3B31-415B-A6DB-B33805686550Q42014838-C6DB8D6F-CF34-4E63-8CCB-120F3F1CECC2Q42128666-FC1F9461-D01C-4A30-B3D5-B0C972F3BE89Q42261435-118135F3-4BC6-4F01-8FEE-2CEF00EA01C3Q45340890-0EB6C09D-6E57-41F2-92E9-960B7F4D937F
P2860
Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Nuclear translocation of p65 N ...... P-1 expression and interaction
@ast
Nuclear translocation of p65 N ...... P-1 expression and interaction
@en
Nuclear translocation of p65 N ...... P-1 expression and interaction
@nl
type
label
Nuclear translocation of p65 N ...... P-1 expression and interaction
@ast
Nuclear translocation of p65 N ...... P-1 expression and interaction
@en
Nuclear translocation of p65 N ...... P-1 expression and interaction
@nl
prefLabel
Nuclear translocation of p65 N ...... P-1 expression and interaction
@ast
Nuclear translocation of p65 N ...... P-1 expression and interaction
@en
Nuclear translocation of p65 N ...... P-1 expression and interaction
@nl
P2093
P2860
P1433
P1476
Nuclear translocation of p65 N ...... P-1 expression and interaction
@en
P2093
A Hamid Boulares
Amarjit S Naura
Charles Nichols
Chetan P Hans
Mourad Zerfaoui
Yasuhiro Suzuki
P2860
P304
P356
10.1016/J.CELLSIG.2007.10.007
P407
P577
2008-01-01T00:00:00Z